The disparity between the availability of medical devices for paediatric and adult patients has recently sparked regulatory, academic, scientific, and economic debate in the United States. There are a host of reasons for this gap, and the FDA has initiatives in place that are addressing the lack of medical devices for children. For paediatric patients, healthcare providers rely on off-label use of
devices approved for adults when there are no other options. Jamie Polychrones of Clarivate identifies why this has proven to be risky and ineffective in some cases.